A recent study from Karolinska Institutet published in The Journal of Clinical Investigation shows that vitamin C and other antioxidants cause the growth of new blood vessels in lung cancer tumours. The discovery supports the notion that antioxidant-rich dietary supplements can hasten cancer
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
Researchers at the University of Florida College of Medicine have uncovered how typical ageing-related blood system alterations can cause some colon tumours to spread more quickly.
According to recent research published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumor-inhibiting genetic cargo boosts the immune system and supports immunotherapy in reducing or totally eradicating aggressive tumours in mice. The findings pave the path
For the first time, researchers discovered a potential drug candidate that improved outcomes for patients suffering from a type of childhood brain tumour that has no effective treatment. When compared to previous patients, the compound, called ONC201, nearly doubled survival for patients wit
According to a new study published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumour-inhibiting genetic cargo promotes the immune system and aids immunotherapy in shrinking or completely clearing aggressive tumours in mice. The findings pave the way f
A new mechanism has been discovered to explain why some prostate tumours move from a common, treatable form to a more rare and severe form of prostate cancer, according to a study from the University of Michigan Rogel Cancer Centre.
In cancer patients with a BMI higher than 30 (the range for obesity determined by the Centers for Disease Control and Prevention), the researchers found a particular pattern in the type of immune cells surrounding cancerous tumours.
The body's lymph nodes serve as one of its first lines of defence against sickness. From these biological police stations, immune cells are sent out to repel invaders. However, the majority of metastatic tumours also start in lymph nodes.
According to a recent Yale study, cancer cells with extra chromosomes depend on those chromosomes for tumour growth, and eliminating them prevents the cells from developing into tumours. The researchers' findings suggest that a unique strategy for treating cancer may involve selectively targ
A new Yale study found that cancer cells with extra chromosomes rely on those chromosomes for tumour formation, and eliminating them prevents the cells from developing tumours. The findings suggested the prospect of a revolutionary cancer therapy technique that selectively targets extra chro
Cancer cells with extra chromosomes rely on those chromosomes for tumour growth, according to a new Yale study, and removing them inhibits the cells from becoming tumours. According to the researchers, the findings show that specifically targeting additional chromosomes may offer a novel app